Ignite Creation Date:
2024-05-06 @ 2:19 PM
Last Modification Date:
2024-10-26 @ 1:29 PM
Study NCT ID:
NCT04286711
Status:
UNKNOWN
Last Update Posted:
2020-02-27
First Post:
2020-02-25
Brief Title:
Clinical Study of Albumin-paclitaxel Combined With Apatinib and Camrelizumab in Advanced Gastric Cancer
Sponsor:
China Medical University China
Organization:
China Medical University China
Organization Data
Organization:
China Medical University China
Class:
OTHER
Study ID:
MA-GC-I-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
China Medical University China
Lead Sponsor Class:
OTHER
Responsible Party:
Yunpeng Liu
Responsible Party Title:
Director of Department of Medical OncologyThe First Hospital of China Medical University
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
China Medical University China
Old Name:
None
Old Organization:
None